PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
108.25%
Total 13F principal
$1,967,000
Principal change
-$10,821,008
Total reported market value
$2,131,773
Number of holders
2
Value change
-$11,410,618
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q3 2020

As of 30 Sep 2020, PDL BIOPHARMA INC - NOTE 2.750%12/0 was held by 2 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $1,967,000 in principal (par value) of the bond. The largest 2 bondholders included Pinnacle Holdings, LLC and UNITED CAPITAL FINANCIAL ADVISERS, LLC. This page lists 2 institutional bondholders reporting positions for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.